GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Novo Nordisk A/S NOVO B.CO · DKK

Health Care · Nasdaq Copenhagen · 🇩🇰 Denmark

Compare

272.80

+1.24%

Close of 9 Nov 2026, in DKK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

34 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 5Strong buy
  • 8Buy
  • 19Hold
  • 2Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Last close 272.80Average target 367.63

Low
267.65
Average
367.63
Median
357.00
High
567.00

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueDKK 299.71bnDKK 304.05bnDKK 326.75bnDKK 350.36bnDKK 380.22bn
Revenue, highestDKK 333.77bnDKK 346.72bnDKK 434.71bnDKK 427.31bnDKK 456.04bn
Revenue, lowestDKK 272.68bnDKK 286.94bnDKK 248.60bnDKK 299.56bnDKK 305.61bn
Earnings per share21.5021.8423.8427.2030.53
Earnings per share, highest23.6026.5135.2134.0338.39
Earnings per share, lowest18.5919.4016.0822.1122.98
Analysts2727356

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Forecast5.964.846.036.285.906.084.715.29
Reported6.044.505.966.536.346.124.495.68
Difference+1.4%-7.0%-1.1%+3.9%+7.5%+0.6%-4.7%+7.5%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

9 / 10

Revenue growth 11.1% a year over 10 years. Return on equity 52.8%.

Model fair value

529.70

From earnings 529.70, from revenue 562.70.

Piotroski score

5 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.